-
公开(公告)号:TR200103709T2
公开(公告)日:2002-08-21
申请号:TR200103709
申请日:2000-06-23
Applicant: BASF AG
Inventor: POMPEJUS MARKUS , KROEGER BURKHARD , SCHROEDER HARTWIG , ZELDER OSKAR , HABERHAUER GREGOR , LEE HEUNG-SHICK , KIM HYUNG-JOON
IPC: G01N33/53 , C07K20060101 , C07K14/34 , C12N20060101 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N9/00 , C12N9/18 , C12N15/09 , C12N15/31 , C12P20060101 , C12P1/04 , C12P13/04 , C12P21/02 , C12Q20060101 , C12Q1/04 , C12Q1/68 , C12R1/13 , C12R1/15 , C12R1/16 , G01N33/569 , G01N37/00
Abstract: Isolated nucleic acid molecules, designated SRT nucleic acid molecules, which encode novel SRT proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing SRT nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated SRT proteins, mutated SRT proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from C. glutamicum based on genetic engineering of SRT genes in this organism.
-
公开(公告)号:TR200103708T2
公开(公告)日:2002-08-21
申请号:TR200103708
申请日:2000-06-23
Applicant: BASF AG
Inventor: POMPEJUS MARKUS , KROEGER BURKHARD , SCHROEDER HARTWIG , ZELDER OSKAR , HABERHAUER GREGOR
IPC: G01N33/53 , C07K20060101 , C07K14/34 , C12N20060101 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N9/00 , C12N9/18 , C12N15/09 , C12N15/31 , C12N15/52 , C12P20060101 , C12P1/04 , C12P13/04 , C12P21/02 , C12Q20060101 , C12Q1/04 , C12Q1/68 , C12R1/13 , C12R1/15 , C12R1/16 , G01N33/569
Abstract: Isolated nucleic acid molecules, designated MCT nucleic acid molecules, which encode novel MCT proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing MCT nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated MCT proteins, mutated MCT proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from C. glutamicum based on genetic engineering of MCT genes in this organism.
-
公开(公告)号:BR0011811A
公开(公告)日:2002-06-18
申请号:BR0011811
申请日:2000-06-23
Applicant: BASF AG
Inventor: POMPEJUS MARKUS , KROEGER BURKHARD , SCHROEDER HARTWIG , ZELDER OSKAR , HABERHAUER GREGOR , LEE HEUNG-SHICK , KIM HYUNG-JOON
IPC: C12N15/00
-
公开(公告)号:BR0011805A
公开(公告)日:2002-05-14
申请号:BR0011805
申请日:2000-06-23
Applicant: BASF AG
Inventor: POMPEJUS MARKUS , KROEGER BURKHARD , SCHROEDER HARTWIG , ZELDER OSKAR , HABERHAUER GREGOR
-
公开(公告)号:CA2592965A1
公开(公告)日:2001-01-04
申请号:CA2592965
申请日:2000-06-23
Applicant: BASF AG
Inventor: KROEGER BURKHARD , POMPEJUS MARKUS , SCHROEDER HARTWIG , ZELDER OSKAR , HABERHAUER GREGOR
IPC: C12N15/56 , C12N9/26 , C12N15/31 , C12N15/63 , C12P1/04 , C12P13/04 , C12P21/00 , C12Q1/68 , G01N33/569 , G01N33/573
-
公开(公告)号:CA2585184A1
公开(公告)日:2001-01-04
申请号:CA2585184
申请日:2000-06-23
Applicant: BASF AG
Inventor: LEE HEUNG-SHICK , KIM HYUNG-JOON , KROEGER BURKHARD , POMPEJUS MARKUS , ZELDER OSKAR , HABERHAUER GREGOR , SCHROEDER HARTWIG
-
107.
公开(公告)号:CA2380863A1
公开(公告)日:2001-01-04
申请号:CA2380863
申请日:2000-06-23
Applicant: BASF AG
Inventor: ZELDER OSKAR , POMPEJUS MARKUS , SCHROEDER HARTWIG , KROEGER BURKHARD , HABERHAUER GREGOR
IPC: G01N33/53 , C07K20060101 , C07K14/34 , C12N20060101 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N9/00 , C12N9/18 , C12N15/09 , C12N15/31 , C12N15/52 , C12P20060101 , C12P1/04 , C12P13/04 , C12P21/02 , C12Q20060101 , C12Q1/04 , C12Q1/68 , C12R1/13 , C12R1/15 , C12R1/16 , G01N33/569
Abstract: Isolated nucleic acid molecules, designated MCT nucleic acid molecules, whic h encode novel MCT proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing MCT nucleic acid molecules, and host cells int o which the expression vectors have been introduced. The invention still furth er provides isolated MCT proteins, mutated MCT proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desire d compound from C. glutamicum based on genetic engineering of MCT genes in thi s organism.
-
公开(公告)号:NO20006153D0
公开(公告)日:2000-12-04
申请号:NO20006153
申请日:2000-12-04
Applicant: BASF AG
Inventor: KOCK MICHAEL , HOEGER THOMAS , KROEGER BURKHARD , OTTERBACH BERND , LUBISCH WILFRIED , LEMAIRE HANS-GEORG
IPC: A01K67/027 , A61K38/00 , A61K38/45 , A61K48/00 , A61K49/00 , A61P43/00 , C07K14/455 , C12N1/15 , C12N1/19 , C12N5/10 , C12N9/10 , C12N15/09 , C12N15/54 , C12Q1/68 , G01N33/53 , C12N
Abstract: The invention relates to poly(ADP-ribose)polymerase (PARP) homologs which have an amino acid sequence which has a) a functional NAD+ binding domain and b) no zinc finger sequence motif of the general formula CX2CXmHX2C in which m is an integral value from 28 or 30, and the X radicals are, independently of one another, any amino acid; and the functional equivalents thereof; nucleic acids coding therefor; antibodies with specificity for the novel protein; pharmaceutical and gene therapy compositions which comprise products according to the invention; methods for the analytical determination of the proteins and nucleic acids according to the invention; methods for identifying effectors or binding partners of the proteins according to the invention; novel PARP effectors; and methods for determining the activity of such effectors.
-
-
公开(公告)号:DK0610246T3
公开(公告)日:1998-01-12
申请号:DK92920588
申请日:1992-09-23
Applicant: BASF AG
Inventor: BIALOJAN SIEGFRIED , FRIEDRICH THOMAS , KOERWER WOLFGANG , KROEGER BURKHARD
IPC: A61K35/64 , A61K38/00 , A61K38/55 , A61P7/02 , C07K1/14 , C07K14/435 , C07K14/81 , C12N15/09 , C12N15/15 , C12P21/02
Abstract: PCT No. PCT/EP92/02198 Sec. 371 Date Mar. 18, 1994 Sec. 102(e) Date Mar. 18, 1994 PCT Filed Sep. 23, 1992 PCT Pub. No. WO93/09231 PCT Pub. Date May 13, 1993A novel thrombin inhibitory protein from ticks with a molecular weight of about 26000 dalton and the partial amino acid sequences Val-Ala-Lys-Phe-Ala-X-Asn-Ser-Gly-Ser-Glu-Thr-Gly (SEQ ID NO: 8), His-Ala-Y-Phe-Glu (SEQ ID NO: 3), Arg-Val-Ser-Asp-Phe-Glu (SEQ ID NO: 4), Phe-Val-Tyr-Thr-Ile-Glu (SEQ ID NO: 6), where X and Y can be identical or different and each is a naturally occurring amino acid, is suitable for controlling diseases.
-
-
-
-
-
-
-
-
-